Tissue engineering is the process of replicating a tissue's structural and spatial structure or function using cells and scaffolds. The goal of an ideal engineered tissue determines how it is made. Biocompatibility and the creation of a tissue that can imitate most of its natural biological functions are the major problems for therapeutic applications. Furthermore, an implanted tissue's vitality is linked to its ability to support circulatory networks. For various self-assembled tissues, adjustments and alterations in stromal thickness and extracellular matrix composition are described. Methods for producing tissue with a morphology and structure that closely resembles that of the native tissue, for incorporating capillary-like networks, and for reducing production time and costs are also discussed. The self-assembly approach produces a stroma that is free of exogenous material and can be used to create the fastest, cheapest, and closest-to-native tissue bioengineering for medicinal and basic research applications.
Title : Side effect free cancer chemotherapy by directed gene delivery using nanomaterials
A C Matin, Stanford University School of Medicine, United States
Title : Artificial intelligence (AI) in biomedical engineering
Hossein Hosseinkhani, Innovation Center for Advanced Technology, Matrix HT, United States
Title : Novel gene therapy options for pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Challenges in skeletal tissue engineering
Patrizia Ferretti, UCL Great Ormond Street Institute of Child Health, United Kingdom
Title : Electroactive polymer-based smart scaffolds for tissue engineering and regenerative medicine
Federico Carpi, University of Florence, Italy
Title : Remote activation of mechanotransduction via integrin alpha-5 by aptamer conjugated magnetic nanoparticles promotes osteogenesis
Hadi Hajiali, University of Birmingham, United Kingdom